Global Buclizine Market Growth 2020-2025
COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.
According to this latest study, the 2020 growth of Buclizine will have significant change from previous year. By the most conservative estimates of global Buclizine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Buclizine market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.
This report presents a comprehensive overview, market shares, and growth opportunities of Buclizine market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Buclizine, covering the supply chain analysis, impact assessment to the Buclizine market size growth rate in several scenarios, and the measures to be undertaken by Buclizine companies in response to the COVID-19 epidemic.
Segmentation by access channel: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Hospital
Drug Store
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Antiallergic Agent
Histamine H₁-Receptor Antagonist
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Stuart Pharmaceuticals
Peili Pharmaceutical
Laboratorios Rocnarf
Mankind Pharma
Johnson and Johnson
UCB
MK Pharma
Meider Pharma
HUA Shin Chemical Pharmaceutical
Sanofi
Pfizer
Al Pharm
Sinphar
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Buclizine consumption (value & volume) by key regions/countries, access channel and medical uses, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Buclizine market by identifying its various subsegments.
Focuses on the key global Buclizine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Buclizine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Buclizine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Buclizine?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Buclizine Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Buclizine Consumption 2015-2025
2.1.2 Buclizine Consumption CAGR by Region
2.2 Buclizine Segment by Access Channel
2.2.1 Hospital
2.2.2 Drug Store
2.3 Buclizine Consumption by Access Channel
2.3.1 Global Buclizine Consumption Market Share by Access Channel (2015-2020)
2.3.2 Global Buclizine Revenue and Market Share by Access Channel (2015-2020)
2.3.3 Global Buclizine Sale Price by Access Channel (2015-2020)
2.4 Buclizine Segment by Medical Uses
2.4.1 Antiallergic Agent
2.4.2 Histamine H₁-Receptor Antagonist
2.5 Buclizine Consumption by Medical Uses
2.5.1 Global Buclizine Consumption Market Share by Access Channel (2015-2020)
2.5.2 Global Buclizine Value and Market Share by Access Channel (2015-2020)
2.5.3 Global Buclizine Sale Price by Access Channel (2015-2020)
3 Global Buclizine by Company
3.1 Global Buclizine Sales Market Share by Company
3.1.1 Global Buclizine Sales by Company (2018-2020)
3.1.2 Global Buclizine Sales Market Share by Company (2018-2020)
3.2 Global Buclizine Revenue Market Share by Company
3.2.1 Global Buclizine Revenue by Company (2018-2020)
3.2.2 Global Buclizine Revenue Market Share by Company (2018-2020)
3.3 Global Buclizine Sale Price by Company
3.4 Global Buclizine Manufacturing Base Distribution, Sales Area, Access Channel by Company
3.4.1 Global Buclizine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Buclizine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Buclizine by Regions
4.1 Buclizine by Regions
4.2 Americas Buclizine Consumption Growth
4.3 APAC Buclizine Consumption Growth
4.4 Europe Buclizine Consumption Growth
4.5 Middle East & Africa Buclizine Consumption Growth
5 Americas
5.1 Americas Buclizine Consumption by Countries
5.1.1 Americas Buclizine Consumption by Countries (2015-2020)
5.1.2 Americas Buclizine Value by Countries (2015-2020)
5.2 Americas Buclizine Consumption by Access Channel
5.3 Americas Buclizine Consumption by Medical Uses
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Buclizine Consumption by Regions
6.1.1 APAC Buclizine Consumption by Regions (2015-2020)
6.1.2 APAC Buclizine Value by Regions (2015-2020)
6.2 APAC Buclizine Consumption by Access Channel
6.3 APAC Buclizine Consumption by Medical Uses
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Buclizine by Countries
7.1.1 Europe Buclizine Consumption by Countries (2015-2020)
7.1.2 Europe Buclizine Value by Countries (2015-2020)
7.2 Europe Buclizine Consumption by Access Channel
7.3 Europe Buclizine Consumption by Medical Uses
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Buclizine by Countries
8.1.1 Middle East & Africa Buclizine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Buclizine Value by Countries (2015-2020)
8.2 Middle East & Africa Buclizine Consumption by Access Channel
8.3 Middle East & Africa Buclizine Consumption by Medical Uses
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Buclizine Distributors
10.3 Buclizine Customer
11 Global Buclizine Market Forecast
11.1 Global Buclizine Consumption Forecast (2021-2025)
11.2 Global Buclizine Forecast by Regions
11.2.1 Global Buclizine Forecast by Regions (2021-2025)
11.2.2 Global Buclizine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Buclizine Forecast by Access Channel
11.8 Global Buclizine Forecast by Medical Uses
12 Key Players Analysis
12.1 Stuart Pharmaceuticals
12.1.1 Company Information
12.1.2 Buclizine Product Offered
12.1.3 Stuart Pharmaceuticals Buclizine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Stuart Pharmaceuticals Latest Developments
12.2 Peili Pharmaceutical
12.2.1 Company Information
12.2.2 Buclizine Product Offered
12.2.3 Peili Pharmaceutical Buclizine Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Peili Pharmaceutical Latest Developments
12.3 Laboratorios Rocnarf
12.3.1 Company Information
12.3.2 Buclizine Product Offered
12.3.3 Laboratorios Rocnarf Buclizine Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Laboratorios Rocnarf Latest Developments
12.4 Mankind Pharma
12.4.1 Company Information
12.4.2 Buclizine Product Offered
12.4.3 Mankind Pharma Buclizine Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Mankind Pharma Latest Developments
12.5 Johnson and Johnson
12.5.1 Company Information
12.5.2 Buclizine Product Offered
12.5.3 Johnson and Johnson Buclizine Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Johnson and Johnson Latest Developments
12.6 UCB
12.6.1 Company Information
12.6.2 Buclizine Product Offered
12.6.3 UCB Buclizine Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 UCB Latest Developments
12.7 MK Pharma
12.7.1 Company Information
12.7.2 Buclizine Product Offered
12.7.3 MK Pharma Buclizine Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 MK Pharma Latest Developments
12.8 Meider Pharma
12.8.1 Company Information
12.8.2 Buclizine Product Offered
12.8.3 Meider Pharma Buclizine Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Meider Pharma Latest Developments
12.9 HUA Shin Chemical Pharmaceutical
12.9.1 Company Information
12.9.2 Buclizine Product Offered
12.9.3 HUA Shin Chemical Pharmaceutical Buclizine Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 HUA Shin Chemical Pharmaceutical Latest Developments
12.10 Sanofi
12.10.1 Company Information
12.10.2 Buclizine Product Offered
12.10.3 Sanofi Buclizine Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Sanofi Latest Developments
12.11 Pfizer
12.11.1 Company Information
12.11.2 Buclizine Product Offered
12.11.3 Pfizer Buclizine Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Pfizer Latest Developments
12.12 Al Pharm
12.12.1 Company Information
12.12.2 Buclizine Product Offered
12.12.3 Al Pharm Buclizine Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Al Pharm Latest Developments
12.13 Sinphar
12.13.1 Company Information
12.13.2 Buclizine Product Offered
12.13.3 Sinphar Buclizine Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Sinphar Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Buclizine Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Buclizine Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Buclizine Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of Hospital
Table 7. Major Players of Drug Store
Table 8. Global Consumption Sales by Access Channel (2015-2020)
Table 9. Global Buclizine Consumption Market Share by Access Channel (2015-2020)
Table 10. Global Buclizine Revenue by Access Channel (2015-2020) ($ million)
Table 11. Global Buclizine Value Market Share by Access Channel (2015-2020) ($ Millions)
Table 12. Global Buclizine Sale Price by Access Channel (2015-2020)
Table 13. Global Consumption Sales by Medical Uses (2015-2020)
Table 14. Global Buclizine Consumption Market Share by Medical Uses (2015-2020)
Table 15. Global Buclizine Value by Medical Uses (2015-2020)
Table 16. Global Buclizine Value Market Share by Medical Uses (2015-2020)
Table 17. Global Buclizine Sale Price by Medical Uses (2015-2020)
Table 18. Global Buclizine Sales by Company (2017-2019) (K Units)
Table 19. Global Buclizine Sales Market Share by Company (2017-2019)
Table 20. Global Buclizine Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Buclizine Revenue Market Share by Company (2017-2019)
Table 22. Global Buclizine Sale Price by Company (2017-2019)
Table 23. Global Buclizine Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Buclizine Products Offered
Table 25. Buclizine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Buclizine Consumption by Regions 2015-2020 (K Units)
Table 27. Global Buclizine Consumption Market Share by Regions 2015-2020
Table 28. Global Buclizine Value by Regions 2015-2020 ($ Millions)
Table 29. Global Buclizine Value Market Share by Regions 2015-2020
Table 30. Americas Buclizine Consumption by Countries (2015-2020) (K Units)
Table 31. Americas Buclizine Consumption Market Share by Countries (2015-2020)
Table 32. Americas Buclizine Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Buclizine Value Market Share by Countries (2015-2020)
Table 34. Americas Buclizine Consumption by Type (2015-2020) (K Units)
Table 35. Americas Buclizine Consumption Market Share by Access Channel (2015-2020)
Table 36. Americas Buclizine Consumption by Medical Uses (2015-2020) (K Units)
Table 37. Americas Buclizine Consumption Market Share by Medical Uses (2015-2020)
Table 38. APAC Buclizine Consumption by Countries (2015-2020) (K Units)
Table 39. APAC Buclizine Consumption Market Share by Countries (2015-2020)
Table 40. APAC Buclizine Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Buclizine Value Market Share by Regions (2015-2020)
Table 42. APAC Buclizine Consumption by Access Channel (2015-2020) (K Units)
Table 43. APAC Buclizine Consumption Market Share by Access Channel (2015-2020)
Table 44. APAC Buclizine Consumption by Medical Uses (2015-2020) (K Units)
Table 45. APAC Buclizine Consumption Market Share by Medical Uses (2015-2020)
Table 46. Europe Buclizine Consumption by Countries (2015-2020) (K Units)
Table 47. Europe Buclizine Consumption Market Share by Countries (2015-2020)
Table 48. Europe Buclizine Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Buclizine Value Market Share by Countries (2015-2020)
Table 50. Europe Buclizine Consumption by Type (2015-2020) (K Units)
Table 51. Europe Buclizine Consumption Market Share by Access Channel (2015-2020)
Table 52. Europe Buclizine Consumption by Medical Uses (2015-2020) (K Units)
Table 53. Europe Buclizine Consumption Market Share by Medical Uses (2015-2020)
Table 54. Middle East & Africa Buclizine Consumption by Countries (2015-2020) (K Units)
Table 55. Middle East & Africa Buclizine Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Buclizine Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Buclizine Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Buclizine Consumption by Access Channel (2015-2020) (K Units)
Table 59. Middle East & Africa Buclizine Consumption Market Share by Access Channel (2015-2020)
Table 60. Middle East & Africa Buclizine Consumption by Medical Uses (2015-2020) (K Units)
Table 61. Middle East & Africa Buclizine Consumption Market Share by Medical Uses (2015-2020)
Table 62. Buclizine Distributors List
Table 63. Buclizine Customer List
Table 64. Global Buclizine Consumption Forecast by Countries (2021-2025) (K Units)
Table 65. Global Buclizine Consumption Market Forecast by Regions
Table 66. Global Buclizine Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Buclizine Value Market Share Forecast by Regions
Table 68. Global Buclizine Consumption Forecast by Access Channel (2021-2025) (K Units)
Table 69. Global Buclizine Consumption Market Share Forecast by Access Channel (2021-2025)
Table 70. Global Buclizine Value Forecast by Access Channel (2021-2025) ($ Millions)
Table 71. Global Buclizine Value Market Share Forecast by Access Channel (2021-2025)
Table 72. Global Buclizine Consumption Forecast by Medical Uses (2021-2025) (K Units)
Table 73. Global Buclizine Consumption Market Share Forecast by Medical Uses (2021-2025)
Table 74. Global Buclizine Value Forecast by Medical Uses (2021-2025) ($ Millions)
Table 75. Global Buclizine Value Market Share Forecast by Medical Uses (2021-2025)
Table 76. Stuart Pharmaceuticals Product Offered
Table 77. Stuart Pharmaceuticals Buclizine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 78. Stuart Pharmaceuticals Main Business
Table 79. Stuart Pharmaceuticals Latest Developments
Table 80. Stuart Pharmaceuticals Basic Information, Company Total Revenue (in $ million), Buclizine Manufacturing Base, Sales Area and Its Competitors
Table 81. Peili Pharmaceutical Product Offered
Table 82. Peili Pharmaceutical Buclizine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 83. Peili Pharmaceutical Main Business
Table 84. Peili Pharmaceutical Latest Developments
Table 85. Peili Pharmaceutical Basic Information, Company Total Revenue (in $ million), Buclizine Manufacturing Base, Sales Area and Its Competitors
Table 86. Laboratorios Rocnarf Product Offered
Table 87. Laboratorios Rocnarf Buclizine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 88. Laboratorios Rocnarf Main Business
Table 89. Laboratorios Rocnarf Latest Developments
Table 90. Laboratorios Rocnarf Basic Information, Company Total Revenue (in $ million), Buclizine Manufacturing Base, Sales Area and Its Competitors
Table 91. Mankind Pharma Product Offered
Table 92. Mankind Pharma Buclizine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 93. Mankind Pharma Main Business
Table 94. Mankind Pharma Latest Developments
Table 95. Mankind Pharma Basic Information, Company Total Revenue (in $ million), Buclizine Manufacturing Base, Sales Area and Its Competitors
Table 96. Johnson and Johnson Product Offered
Table 97. Johnson and Johnson Buclizine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 98. Johnson and Johnson Main Business
Table 99. Johnson and Johnson Latest Developments
Table 100. Johnson and Johnson Basic Information, Company Total Revenue (in $ million), Buclizine Manufacturing Base, Sales Area and Its Competitors
Table 101. UCB Product Offered
Table 102. UCB Buclizine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 103. UCB Main Business
Table 104. UCB Latest Developments
Table 105. UCB Basic Information, Company Total Revenue (in $ million), Buclizine Manufacturing Base, Sales Area and Its Competitors
Table 106. MK Pharma Product Offered
Table 107. MK Pharma Basic Information, Company Total Revenue (in $ million), Buclizine Manufacturing Base, Sales Area and Its Competitors
Table 108. MK Pharma Main Business
Table 109. MK Pharma Latest Developments
Table 110. MK Pharma Buclizine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 111. Meider Pharma Product Offered
Table 112. Meider Pharma Buclizine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 113. Meider Pharma Main Business
Table 114. Meider Pharma Latest Developments
Table 115. Meider Pharma Basic Information, Company Total Revenue (in $ million), Buclizine Manufacturing Base, Sales Area and Its Competitors
Table 116. HUA Shin Chemical Pharmaceutical Product Offered
Table 117. HUA Shin Chemical Pharmaceutical Buclizine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 118. HUA Shin Chemical Pharmaceutical Main Business
Table 119. HUA Shin Chemical Pharmaceutical Latest Developments
Table 120. HUA Shin Chemical Pharmaceutical Basic Information, Company Total Revenue (in $ million), Buclizine Manufacturing Base, Sales Area and Its Competitors
Table 121. Sanofi Product Offered
Table 122. Sanofi Buclizine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 123. Sanofi Main Business
Table 124. Sanofi Latest Developments
Table 125. Sanofi Basic Information, Company Total Revenue (in $ million), Buclizine Manufacturing Base, Sales Area and Its Competitors
Table 126. Pfizer Product Offered
Table 127. Pfizer Buclizine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 128. Pfizer Main Business
Table 129. Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 130. Pfizer Latest Developments
Table 131. Al Pharm Product Offered
Table 132. Al Pharm Buclizine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 133. Al Pharm Main Business
Table 134. Al Pharm Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 135. Al Pharm Latest Developments
Table 136. Sinphar Product Offered
Table 137. Sinphar Buclizine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 138. Sinphar Main Business
Table 139. Sinphar Latest Developments
Table 140. Sinphar Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Buclizine
Figure 2. Buclizine Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Buclizine Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Buclizine Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Hospital
Figure 7. Product Picture of Drug Store
Figure 8. Global Buclizine Consumption Market Share by Access Channel (2015-2020)
Figure 9. Global Buclizine Value Market Share by Access Channel (2015-2020)
Figure 10. Buclizine Consumed in Antiallergic Agent
Figure 11. Global Buclizine Market: Antiallergic Agent (2015-2020) (K Units)
Figure 12. Global Buclizine Market: Antiallergic Agent (2015-2020) ($ Millions)
Figure 13. Buclizine Consumed in Histamine H₁-Receptor Antagonist
Figure 14. Global Buclizine Market: Histamine H₁-Receptor Antagonist (2015-2020) (K Units)
Figure 15. Global Buclizine Market: Histamine H₁-Receptor Antagonist (2015-2020) ($ Millions)
Figure 16. Global Buclizine Consumption Market Share by Medical Uses (2015-2020)
Figure 17. Global Buclizine Value Market Share by Medical Uses (2015-2020)
Figure 18. Global Buclizine Sales Market Share by Company in 2017
Figure 19. Global Buclizine Sales Market Share by Company in 2019
Figure 20. Global Buclizine Revenue Market Share by Company in 2017
Figure 21. Global Buclizine Revenue Market Share by Company in 2019
Figure 22. Global Buclizine Sale Price by Company in 2019
Figure 23. Global Buclizine Consumption Market Share by Regions 2015-2020
Figure 24. Global Buclizine Value Market Share by Regions 2015-2020
Figure 25. Americas Buclizine Consumption 2015-2020 (K Units)
Figure 26. Americas Buclizine Value 2015-2020 ($ Millions)
Figure 27. APAC Buclizine Consumption 2015-2020 (K Units)
Figure 28. APAC Buclizine Value 2015-2020 ($ Millions)
Figure 29. Europe Buclizine Consumption 2015-2020 (K Units)
Figure 30. Europe Buclizine Value 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Buclizine Consumption 2015-2020 (K Units)
Figure 32. Middle East & Africa Buclizine Value 2015-2020 ($ Millions)
Figure 33. Americas Buclizine Consumption Market Share by Countries in 2019
Figure 34. Americas Buclizine Value Market Share by Countries in 2019
Figure 35. Americas Buclizine Consumption Market Share by Access Channel in 2019
Figure 36. Americas Buclizine Consumption Market Share by Medical Uses in 2019
Figure 37. United States Buclizine Consumption Growth 2015-2020 (K Units)
Figure 38. United States Buclizine Value Growth 2015-2020 ($ Millions)
Figure 39. Canada Buclizine Consumption Growth 2015-2020 (K Units)
Figure 40. Canada Buclizine Value Growth 2015-2020 ($ Millions)
Figure 41. Mexico Buclizine Consumption Growth 2015-2020 (K Units)
Figure 42. Mexico Buclizine Value Growth 2015-2020 ($ Millions)
Figure 43. APAC Buclizine Consumption Market Share by Countries in 2019
Figure 44. APAC Buclizine Value Market Share by Regions in 2019
Figure 45. APAC Buclizine Consumption Market Share by Access Channel in 2019
Figure 46. APAC Buclizine Consumption Market Share by Medical Uses in 2019
Figure 47. China Buclizine Consumption Growth 2015-2020 (K Units)
Figure 48. China Buclizine Value Growth 2015-2020 ($ Millions)
Figure 49. Japan Buclizine Consumption Growth 2015-2020 (K Units)
Figure 50. Japan Buclizine Value Growth 2015-2020 ($ Millions)
Figure 51. Korea Buclizine Consumption Growth 2015-2020 (K Units)
Figure 52. Korea Buclizine Value Growth 2015-2020 ($ Millions)
Figure 53. Southeast Asia Buclizine Consumption Growth 2015-2020 (K Units)
Figure 54. Southeast Asia Buclizine Value Growth 2015-2020 ($ Millions)
Figure 55. India Buclizine Consumption Growth 2015-2020 (K Units)
Figure 56. India Buclizine Value Growth 2015-2020 ($ Millions)
Figure 57. Australia Buclizine Consumption Growth 2015-2020 (K Units)
Figure 58. Australia Buclizine Value Growth 2015-2020 ($ Millions)
Figure 59. Europe Buclizine Consumption Market Share by Countries in 2019
Figure 60. Europe Buclizine Value Market Share by Countries in 2019
Figure 61. Europe Buclizine Consumption Market Share by Access Channel in 2019
Figure 62. Europe Buclizine Consumption Market Share by Medical Uses in 2019
Figure 63. Germany Buclizine Consumption Growth 2015-2020 (K Units)
Figure 64. Germany Buclizine Value Growth 2015-2020 ($ Millions)
Figure 65. France Buclizine Consumption Growth 2015-2020 (K Units)
Figure 66. France Buclizine Value Growth 2015-2020 ($ Millions)
Figure 67. UK Buclizine Consumption Growth 2015-2020 (K Units)
Figure 68. UK Buclizine Value Growth 2015-2020 ($ Millions)
Figure 69. Italy Buclizine Consumption Growth 2015-2020 (K Units)
Figure 70. Italy Buclizine Value Growth 2015-2020 ($ Millions)
Figure 71. Russia Buclizine Consumption Growth 2015-2020 (K Units)
Figure 72. Russia Buclizine Value Growth 2015-2020 ($ Millions)
Figure 73. Middle East & Africa Buclizine Consumption Market Share by Countries in 2019
Figure 74. Middle East & Africa Buclizine Value Market Share by Countries in 2019
Figure 75. Middle East & Africa Buclizine Consumption Market Share by Access Channel in 2019
Figure 76. Middle East & Africa Buclizine Consumption Market Share by Medical Uses in 2019
Figure 77. Egypt Buclizine Consumption Growth 2015-2020 (K Units)
Figure 78. Egypt Buclizine Value Growth 2015-2020 ($ Millions)
Figure 79. South Africa Buclizine Consumption Growth 2015-2020 (K Units)
Figure 80. South Africa Buclizine Value Growth 2015-2020 ($ Millions)
Figure 81. Israel Buclizine Consumption Growth 2015-2020 (K Units)
Figure 82. Israel Buclizine Value Growth 2015-2020 ($ Millions)
Figure 83. Turkey Buclizine Consumption Growth 2015-2020 (K Units)
Figure 84. Turkey Buclizine Value Growth 2015-2020 ($ Millions)
Figure 85. GCC Countries Buclizine Consumption Growth 2015-2020 (K Units)
Figure 86. GCC Countries Buclizine Value Growth 2015-2020 ($ Millions)
Figure 87. Global Buclizine Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 88. Global Buclizine Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 89. Americas Buclizine Consumption 2021-2025 (K Units)
Figure 90. Americas Buclizine Value 2021-2025 ($ Millions)
Figure 91. APAC Buclizine Consumption 2021-2025 (K Units)
Figure 92. APAC Buclizine Value 2021-2025 ($ Millions)
Figure 93. Europe Buclizine Consumption 2021-2025 (K Units)
Figure 94. Europe Buclizine Value 2021-2025 ($ Millions)
Figure 95. Middle East & Africa Buclizine Consumption 2021-2025 (K Units)
Figure 96. Middle East & Africa Buclizine Value 2021-2025 ($ Millions)
Figure 97. United States Buclizine Consumption 2021-2025 (K Units)
Figure 98. United States Buclizine Value 2021-2025 ($ Millions)
Figure 99. Canada Buclizine Consumption 2021-2025 (K Units)
Figure 100. Canada Buclizine Value 2021-2025 ($ Millions)
Figure 101. Mexico Buclizine Consumption 2021-2025 (K Units)
Figure 102. Mexico Buclizine Value 2021-2025 ($ Millions)
Figure 103. Brazil Buclizine Consumption 2021-2025 (K Units)
Figure 104. Brazil Buclizine Value 2021-2025 ($ Millions)
Figure 105. China Buclizine Consumption 2021-2025 (K Units)
Figure 106. China Buclizine Value 2021-2025 ($ Millions)
Figure 107. Japan Buclizine Consumption 2021-2025 (K Units)
Figure 108. Japan Buclizine Value 2021-2025 ($ Millions)
Figure 109. Korea Buclizine Consumption 2021-2025 (K Units)
Figure 110. Korea Buclizine Value 2021-2025 ($ Millions)
Figure 111. Southeast Asia Buclizine Consumption 2021-2025 (K Units)
Figure 112. Southeast Asia Buclizine Value 2021-2025 ($ Millions)
Figure 113. India Buclizine Consumption 2021-2025 (K Units)
Figure 114. India Buclizine Value 2021-2025 ($ Millions)
Figure 115. Australia Buclizine Consumption 2021-2025 (K Units)
Figure 116. Australia Buclizine Value 2021-2025 ($ Millions)
Figure 117. Germany Buclizine Consumption 2021-2025 (K Units)
Figure 118. Germany Buclizine Value 2021-2025 ($ Millions)
Figure 119. France Buclizine Consumption 2021-2025 (K Units)
Figure 120. France Buclizine Value 2021-2025 ($ Millions)
Figure 121. UK Buclizine Consumption 2021-2025 (K Units)
Figure 122. UK Buclizine Value 2021-2025 ($ Millions)
Figure 123. Italy Buclizine Consumption 2021-2025 (K Units)
Figure 124. Italy Buclizine Value 2021-2025 ($ Millions)
Figure 125. Russia Buclizine Consumption 2021-2025 (K Units)
Figure 126. Russia Buclizine Value 2021-2025 ($ Millions)
Figure 127. Spain Buclizine Consumption 2021-2025 (K Units)
Figure 128. Spain Buclizine Value 2021-2025 ($ Millions)
Figure 129. Egypt Buclizine Consumption 2021-2025 (K Units)
Figure 130. Egypt Buclizine Value 2021-2025 ($ Millions)
Figure 131. South Africa Buclizine Consumption 2021-2025 (K Units)
Figure 132. South Africa Buclizine Value 2021-2025 ($ Millions)
Figure 133. Israel Buclizine Consumption 2021-2025 (K Units)
Figure 134. Israel Buclizine Value 2021-2025 ($ Millions)
Figure 135. Turkey Buclizine Consumption 2021-2025 (K Units)
Figure 136. Turkey Buclizine Value 2021-2025 ($ Millions)
Figure 137. GCC Countries Buclizine Consumption 2021-2025 (K Units)
Figure 138. GCC Countries Buclizine Value 2021-2025 ($ Millions)
Figure 139. Stuart Pharmaceuticals Buclizine Market Share (2018-2020)
Figure 140. Peili Pharmaceutical Buclizine Market Share (2018-2020)
Figure 141. Laboratorios Rocnarf Buclizine Market Share (2018-2020)
Figure 142. Mankind Pharma Buclizine Market Share (2018-2020)
Figure 143. Johnson and Johnson Buclizine Market Share (2018-2020)
Figure 144. UCB Buclizine Market Share (2018-2020)
Figure 145. MK Pharma Buclizine Market Share (2018-2020)
Figure 146. Meider Pharma Buclizine Market Share (2018-2020)
Figure 147. HUA Shin Chemical Pharmaceutical Buclizine Market Share (2018-2020)
Figure 148. Sanofi Buclizine Market Share (2018-2020)
Figure 149. Pfizer Buclizine Market Share (2018-2020)
Figure 150. Al Pharm Buclizine Market Share (2018-2020)
Figure 151. Sinphar Buclizine Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets